PHARMACIE DE SAINT-AMAND
0728.698.543 · rovalta.com · 26/09/2026
PHARMACIE DE SAINT-AMAND
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPHARMACIE DE SAINT-AMAND is a Private limited company incorporated in 2019. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Fleurus. It employs on average 0,7 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0728.698.543
- Incorporation
- 20/06/2019
- Legal form
- Private limited company
- Registered office
- Rue Georges Maroye(SA) 26
6221 Fleurus · WallonieSee on map - Contributed capital
- 30 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 0,7 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 160,4 k € | -14.1% | 186,6 k € | -0.7% | 187,9 k € | -3.6% | 195 k € | +41.3% | 138 k € |
| EBITDA | 110,2 k € | -24.9% | 146,8 k € | +18.9% | 123,5 k € | -10.7% | 138,3 k € | +7.8% | 128,3 k € |
| Operating result | 51,4 k € | -41.3% | 87,5 k € | +36.0% | 64,3 k € | -19.1% | 79,5 k € | +14.0% | 69,7 k € |
| Net result | 31 k € | -47.2% | 58,7 k € | +42.5% | 41,2 k € | -23.5% | 53,9 k € | +18.1% | 45,6 k € |
| Balance sheet | |||||||||
| Equity | 272,1 k € | +12.9% | 241,1 k € | +32.2% | 182,4 k € | +29.2% | 141,2 k € | +61.7% | 87,3 k € |
| Total assets | 965,6 k € | -3.5% | 1 M € | -2.3% | 1 M € | -3.6% | 1,1 M € | -4.6% | 1,1 M € |
| Cash | 75,9 k € | +26.9% | 59,8 k € | +24.4% | 48,1 k € | -33.1% | 71,9 k € | +8.3% | 66,4 k € |
| Debts | 691,6 k € | -8.7% | 757,6 k € | -10.0% | 842 k € | -8.7% | 922 k € | -10.3% | 1 M € |
| Other | |||||||||
| Workforce | 0,7 ETP | +16.7% | 0,6 ETP | -45.5% | 1,1 ETP | +10.0% | 1,0 ETP | +400% | 0,2 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 20/06/2019 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 19 months |
| Filing date | 25/08/2026 | 04/08/2025 | 29/08/2024 | 20/07/2023 | 29/06/2022 | 09/08/2021 |
| General meeting | 05/06/2026 | 06/06/2025 | 07/06/2024 | 02/06/2023 | 03/06/2022 | 04/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 05/06/2026 | 25/08/2026 | French | |
| Abridged model | 31/12/2024 | 06/06/2025 | 04/08/2025 | French | |
| Abridged model | 31/12/2023 | 07/06/2024 | 29/08/2024 | French | |
| Abridged model | 31/12/2022 | 02/06/2023 | 20/07/2023 | French | |
| Abridged model | 31/12/2021 | 03/06/2022 | 29/06/2022 | French | |
| Abridged model | 31/12/2020 | 04/06/2021 | 09/08/2021 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202531 k €↓
- 2024Annual accounts 202458,7 k €↑
- 2024Name changeSAINT-AMAND PHARMACIE DE
- 2023Annual accounts 202341,2 k €↓
- 2022Annual accounts 202253,9 k €↑
- 2021Annual accounts 202145,6 k €↑
- 2021Name changeBC Pharma
- 2020Annual accounts 202011,7 k €
- 20/06/2019IncorporationPrivate limited company